Verition Fund Management’s Vera Therapeutics VERA Stock Holding History

Verition Fund Management’s Portfolio VERA Stock Details VERA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$972K	Buy	+22,642	New	+$844K	﹤0.01%	1425
2025 Q4	–	Sell	-40,877	Closed	-$1.19M	–	3979
2025 Q3	$1.19M	Buy	+40,877	New	+$945K	﹤0.01%	2396
2025 Q2	–	Sell	-42,769	Closed	-$1.03M	–	3884
2025 Q1	$1.03M	Buy	42,769 +20,874	+95%	+$671K	﹤0.01%	2110
2024 Q4	$926K	Sell	21,895 -21,315	-49%	-$944K	﹤0.01%	2103
2024 Q3	$1.91M	Buy	+43,210	New	+$1.64M	0.01%	1446

Other funds holding VERA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Verition Fund Management's VERA Position: Q2 2026 in Review

Verition Fund Management opened a new position in Vera Therapeutics (VERA) in Q2 2026: 22,642 shares worth $972K. The stake represents ﹤0.01% of the portfolio and ranks #1425 among its holdings. This is a return to the name: Verition Fund Management previously reported a position in VERA as recently as Q3 2025.

Verition Fund Management first reported a position in VERA in Q3 2024 and has held it in 5 quarters since. The position peaked at $1.91M in Q3 2024. 219 funds tracked by Wall St. Rank hold VERA as of Q2 2026.

Verition Fund Management held 22,642 shares of Vera Therapeutics worth $972K as of Q2 2026.
Vera Therapeutics was a new Verition Fund Management position in Q2 2026.
Vera Therapeutics made up ﹤0.01% of Verition Fund Management's portfolio in Q2 2026, its #1425 holding.
Verition Fund Management first reported a position in Vera Therapeutics in Q3 2024 and has held it in 5 quarters since.
Verition Fund Management's Vera Therapeutics position peaked at $1.91M in Q3 2024.
219 funds tracked by Wall St. Rank held Vera Therapeutics as of Q2 2026.

Based on Verition Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.